HealthEquity (HQY)
(Delayed Data from NSDQ)
$87.68 USD
-0.32 (-0.36%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $87.68 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth C Momentum B VGM
Price, Consensus and EPS Surprise
HQY 87.68 -0.32(-0.36%)
Will HQY be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for HQY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for HQY
HealthEquity, Inc. (HQY) Hits Fresh High: Is There Still Room to Run?
Zacks Industry Outlook Highlights Elevance Health, Doximity and HealthEquity
HQY: What are Zacks experts saying now?
Zacks Private Portfolio Services
3 Medical Services Stocks to Buy to Navigate Industry Challenges
HealthEquity Gains 28.3% YTD: What's Driving the Stock?
Here's Why HealthEquity (HQY) is a Strong Momentum Stock
Other News for HQY
Barclays Reaffirms Their Buy Rating on Healthequity (HQY)
HealthEquity launches HSAnswers AI tool
Ophir Asset Management's Strategic Reduction in Harrow Inc Holdings
Ophir Asset Management's Strategic Acquisition in Guardian Pharmacy Services Inc
Here's How Much You Would Have Made Owning HealthEquity Stock In The Last 10 Years